BlincVision (BLINC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
The MVP of BlincVision was launched, featuring integrated hardware/software, improved laser scanner, and advanced AI model, enabling customer evaluations and production for autumn delivery.
Strong technical progress achieved, with rigorous testing and improved features, positioning for commercialization.
Participation in major industry conferences and trade fairs increased visibility and opened new opportunities.
Secured MSEK 40.0 through oversubscribed rights and directed issues, improving financial position.
Received intention to grant first proprietary patent for event-based sensor data processing, expanding IP portfolio.
Financial highlights
Revenue for Q2 and H1 2025 was TSEK 0, compared to TSEK 380 in Q2 2024.
Operating loss for Q2 2025 was TSEK -10,970 (Q2 2024: -9,985); H1 2025 operating loss was TSEK -20,146 (H1 2024: -18,266).
Net loss for Q2 2025 was TSEK -11,633 (Q2 2024: -10,983); H1 2025 net loss was TSEK -21,484 (H1 2024: -20,329).
Cash and cash equivalents at period end were TSEK 16,781 (Dec 2024: 18,541).
Equity/assets ratio improved to 69.8% (Dec 2024: 54.3%).
Outlook and guidance
Customer evaluations of BlincVision MVP to begin in Q3 2025, with feedback guiding further development.
Sufficient liquidity secured to continue operations into Q2 2026, contingent on continued capital raising and commercialization.
Key priorities for Q3 and Q4 include supporting customer evaluations, pursuing commercialization agreements, and defining 2026 plans.
Activities with alternative use cases and new customer segments will intensify in Q4.
Board remains confident in ability to secure future financing and advance commercialization.
Latest events from BlincVision
- Autonomous braking milestone reached, but ongoing financial uncertainty remains.BLINC
Q3 20248 Jul 2026 - MVP testing and new financing extend runway into 2026 despite ongoing losses.BLINC
Q1 20251 Jul 2026 - Expanded into defense, improved operating loss, and maintained strong liquidity while targeting commercialization.BLINC
Q1 20267 May 2026 - BlincVision MVP reached external evaluations, funding secured, and commercialization targeted for 2026.BLINC
Q4 20256 Feb 2026 - BlincVision reached key milestones and SEK 12.6M was raised through warrants.BLINC
Q2 20241 Feb 2026 - BlincVision nears MVP launch with strong funding, team growth, and 2025 commercialization plans.BLINC
Q4 202423 Dec 2025 - BlincVision MVP delivered; losses persist, financing remains critical for continued operations.BLINC
Q3 202524 Oct 2025